Ea. James et al., Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells, PROT EX PUR, 19(1), 2000, pp. 131-138
Human. granulocyte-macrophage colony-stimulating factor (GM-CSF), a hemopoi
etic growth factor, was produced and secreted from tobacco cell suspensions
. The GM-CSF cDNA was carried by a binary vector under the control of the C
aMV 35S promoter and the T7 terminator. In addition, a 5'-nontranslated reg
ion from the tobacco etch virus (TEV leader sequence) was fused to the N-te
rminal end of the GM-CSF transgene, For ease of purification, a g-His tag w
as added to the 3' end of the GM-CSF cDNA. Addition of the TEV leader seque
nce increased protein production more than twofold compared to non-TEV cont
rols, Initial batch cultivation studies indicated a maximum of 250 mu g/L e
xtracellular and 150 mu g/L intracellular GM-CSF. Western blot analysis det
ected multiple peptides with masses from 14 to 30 kDa in the extracellular
medium. The plant-produced GM-CSF was biologically active and could be boun
d to a nickel affinity matrix, indicating that both the receptor-binding re
gion and the g-His tag were functional. The batch production of GM-CSF was
compared with the production of other recombinant proteins secreted by tran
sformed tobacco cells. The recovery of secreted GM-CSF was increased by the
addition of stabilizing proteins and by increasing salt in the growth medi
um to physiological levels. (C) 2000 Academic Press.